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Available online 23 April 2016Atypical benign partial epilepsy (ABPE) of childhood or pseudo-Lennox syndrome is a formof idiopathic focal ep-
ilepsy characterized by multiple seizure types, focal and/or generalized epileptiform discharges, continuous
spike–wave during sleep (CSWS), and sometimes reversible neurocognitive deﬁcits. There are few reported
cases of ABPE describing detailed correlative longitudinal follow-up of the various associated neurocognitive, lan-
guage, social communicative, or motor deﬁcits, in parallel with the epilepsy. Furthermore, the molecular inheri-
tance pattern for ABPE and the wider spectrum of epilepsy aphasia disorders have yet to be fully elucidated. We
describe the phenotype–genotype study of a boy with ABPE with follow-up from ages 5 to 13 years showing ac-
quired oromotor and, later, a speciﬁc lexical semantic and pervasive developmental disorder. Exome sequencing
identiﬁed variants in SCN9A, CPA6, and SCNM1. A direct role of the epilepsy in the pathogenesis of the oromotor
and neurocognitive deﬁcits is apparent.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
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SCNM11. Introduction
The idiopathic focal epilepsies of childhood represent a heteroge-
neous and presumed genetic group of epilepsies for which the underly-
ing molecular mechanisms remain largely undetermined. Atypical
benign partial epilepsy (ABPE) of childhood or pseudo-Lennox syn-
drome is a rare form of idiopathic focal epilepsy characterized bymulti-
ple seizure types including focal seizures, “generalized minor seizures”
(atonic, absence, or myoclonic seizures), and occasional febrile seizures
or status epilepticus [1]. The electroencephalogram (EEG) in ABPE
shows focal or multifocal sharpwaves, a tendency towards changing lo-
cation, generalization, and pronounced activation during sleep often
resulting in continuous spike-and-wave during slow-wave sleep
(CSWS). As such, ABPE is part of the “epilepsy aphasia spectrum” of
disorders where rolandic epilepsy occurs at one end and the Landau–
Kleffner syndrome (LKS) occurs at the more severe end. ABPE is associ-
atedwith reversible or residual deﬁcits in language,motor function, and
cognition. However, prospective studies describing in detail the epilep-
sy and speciﬁc motor, cognitive, social communicative, and language, National University of Ireland
llen).
. This is an open access article underdeﬁcits are rarely reported. With advances in next generation DNA se-
quencing, efforts to correlate the molecular genetic architecture of
these disorders could also be described in conjunctionwith uniquely in-
sightful phenotypes.
This report describes the phenotype of a boywith ABPEwho, follow-
ing a very active seizure period, demonstrated acquired oromotor, lan-
guage, social communicative, and neurocognitive manifestations (with
stabilization and partial improvement upon seizure remission), follow-
ed longitudinally from ages 5 to 13 years. Exome sequencing revealed
variants in SCN9A and two other epilepsy-associated genes, CPA6 and
SCNM1.
2. Methods & results
2.1. Epilepsy, motor, language, cognitive, and social communicative
disorder
2.1.1. Clinical summary
The proband, a boy, was born full term with an unremarkable peri-
natal history to nonconsanguineous Caucasian parents. There was no
family history of seizure or autistic spectrum disorder; however, his
younger sister presented at age 11 years withmild electivemutism, pri-
mary anxiety, andminor sensory processingdifﬁculties (EEG andgenet-
ic characterization were not possible in his sister). When the boy wasthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Representation of the longitudinal correlative (epilepsy, cognitive, speech, and language) course and follow-up.
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milestones were normal including hearing, speech, and language (he
had 3- to 4-word sentences and understood 3-stage commands), and
physical examination was normal. Brain magnetic resonance imaging,
routine biochemistry, hematological indices and chromosomalmicroar-
ray CGH were normal. Later, emergence of left hand preference was
assumed familial (maternal aunt and ﬁrst cousin).
Following initial seizure presentation, hewent to preschool (kinder-
garten) and continued to acquire new skills. His preschool teacher
noted occasional (intermittent)mild speech slurring and pronunciation
difﬁculty, although thesewere not noted by his parents. Hemade accel-
erated progress with reading acquisition and, at age 4 years, was report-
ed by the preschool teacher to have signiﬁcantly advanced word
reading (hyperlexia). Prior to ﬁrst formal neuropsychological assess-
ment (age 5 years), a retrospective review identiﬁed subtle intermittent
aberrations in play pattern (speciﬁc interests) and repetitive behaviors,
after initial seizure onset. During the most active epilepsy period, dete-
rioration in learning and social communication was observed. In addi-
tion, at age 6.2 years, following the onset of the most active epileptic
period (including CSWS and prominent bilateral centrotemporal dis-
charges), language also became severely impaired. Receptive language
declined below expressive language; however, verbal auditory agnosia
(LKS) was not a feature. As seizure control and EEG abnormalities im-
proved, there was recovery in language skills (more in expressive than
receptive), but an overall residual speciﬁc disorder of lexical semantics
affecting both receptive and expressive vocabulary occurred.
In parallel with recurrent perisylvian seizures at age 5 years,
transient motor difﬁculties emerged in the form of right-sided limb
and facial weakness, slurred speech, drooling of saliva, and oromotor
difﬁculties. While general motor improvement occurred following sei-
zure remission, difﬁculties with ﬁne oromotor gestures persist at age
14 years.Details of the epilepsy aswell as language, cognitive, and social com-
munication disorders follow (summarized in Fig. 1 and Supplemental
Table 1).
2.1.2. Epilepsy course
At age 23months, the boy presented with a seizure characterized by
jerking of the right arm and leg, eye-rolling, drooling, and unconscious-
ness. EEG showed left centrotemporal spikes. Over the following 2 years,
while treated with carbamazepine, clusters of brief perisylvian seizures
occurred characterized by right (sometimes left) arm jerking/hand
clenching, facial twitching, and frothing at the mouth. From the age of
4 years, multiple seizure types were seen, affecting either side of the
bodywhile various antiepileptic drugs (AEDs) were ineffective (Supple-
mental Table 1). EEGs showed high amplitude spike–wave discharges
predominantly in the left parietocentral/centrotemporal regions. At
the age of almost 5 years, subtle drop attacks developed. Ongoing sei-
zures included episodes of blinking, facial twitching, and drooling. EEG
continued to show mainly left parietocentral spikes (Fig. 2A). A course
of betamethasone (2 mg/day for 7 weeks) led to seizure remission, but
one week after weaning, seizures recurred. A second course of
betamethasone after 5 weeks achieved seizure freedom, but relapse oc-
curred with attempted weaning. Following dose adjustment, milder
breakthrough seizures continued. Vigabatrin was added, and steroids
weaned after a total of 4 months. At this stage, awake and sleep EEG
showed high-amplitude left and right temporoparietal foci and runs of
epileptiform discharges. Despite further AED modiﬁcation, seizure fre-
quency increased. A third course of betamethasone improved seizures
for 1 month before relapse on steroids at age 6.4 years. Sulthiame and
a course of adrenocorticotrophic hormone (ACTH) signiﬁcantly im-
proved drop attacks; however, following ACTH withdrawal, seizures
worsened, and EEG evolved to CSWS (Fig. 2B). A course of daily prednis-
olone combinedwith ethosuximide achieved seizure freedom forweeks
Fig. 2. (A): EEG (sensitivity 15 μV/mm) at age 5 years showing sharpwavesmainly in the left parietocentral but also independent discharges from the right side, (B) EEG (20 μV/mm)at age
6 years 4 months showing continuous spike–wave during slow wave sleep. While the discharges appear bisynchronous, they are of higher amplitude and appear earlier over the left
centroparietal region.
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prednisolone was switched to a pulsed regimen (25 mg twice weekly),
complete remission of seizures occurred. At follow up, EEGs showed
marked improvement (centrotemporal discharges without CSWS). At
age 14 years, he remains seizure-free (3 years after steroid withdrawal;
see Supplemental Table 1 for epilepsy course and treatment).
2.1.3. Language regression & assessments
Language skills were formally tested from ages 5 to 13 years. These
focused on receptive and expressive language using the Clinical Evalua-
tion of Language Fundamentals (CELF) Preschool Ed. (Editions 3 and 4).
Other assessments included the British Picture Vocabulary Scale (BPVS),
Test for Reception of Grammar (TROG), and Expressive Vocabulary Test
(2nd Ed.). The ﬁrst language assessment at age 5 years was normal,
prior to the most severe epilepsy phase (including the emergence of
CSWS) and associated cognitive deterioration. Soon after, his parents re-
ported unclear speech and less verbal output. Language deterioration
was ﬁrst documented during assessment at age 6.2 years with persis-
tent disordered language proﬁles in subsequent assessments (focusing
on CELF-3 and CELF-4 assessments; Table 1). In particular, receptive
language abilities declined (moderate to severe range) more than ex-
pressive abilities, an atypical pattern. Receptive language scores demon-
strated little variation across the years compared with expressive
language scores which demonstrated greater variation and improve-
ments. The lowest scores in both receptive and expressive language
abilities occurred at age 7.3 years (during which he appeared anxious
and responded slowly).Additional language tests conﬁrmed particular patterns. The British
Picture Vocabulary Scale (BPVS, a test of receptive vocabulary) revealed
a score within the severe impairment range at last follow-up (age
13 years). Additional expressive language assessments included the
Expressive Vocabulary Test (EVT, 2nd Ed., a test of naming ability and
expressive vocabulary) with scores within the moderate impairment
range. These tests indicate impairments in the area of lexical semantics
in both the receptive and expressive language domains. The Test for Re-
ception of Grammar (TROG) (Syntax) (for receptive grammar) scored in
the average range (standard score: 88; age 13 years). Thus, language
structure (syntax andmorphology) was identiﬁed as an area of relative
strength for receptive language along with the ability to produce
grammatically correct sentences (“formulated sentences” subtest
score: 7; CELF-4). Working memory as seen in “recalling sentences”
subtest (score: 11; CELF-4) was also relatively strong.
Subtests pertaining to “understanding spoken paragraphs” or
“semantic relationships” showed weaknesses (understanding and in-
terpretation). The greatest area of difﬁcultywas in the area of lexical se-
mantics, with both receptive and expressive vocabulary impairment.
Scores in the receptive and expressive “word classes” subtests in
the CELF-4 were statistically lower than in other areas of language
development.
2.1.4. Oral motor and speech disorder
The boy's parents reported normal early oromotor develop-
ment prior to the onset of seizures. His preschool teacher reported
occasional slurring of speech and pronunciation errors. Primarily,
Table 1
Summary of pattern of score totals regarding receptive and expressive language assessments, as well as oromotor observations.
Age Receptive Expressive Oromotor skills General comment
5 years 1 month Preschool CELF: 91
(average range)
Preschool CELF: 104
(average range)
Poor tongue movements; reduced elevation,
depression and lateral movements,
particularly to the right side.
Reduced lip rounding
Excellent attention and concentration.
Mild to moderate unintelligibility.
Poor articulation. Hoarse breathy vocal
quality. Hypernasal speech
6 years 2 months CELF-3: 71
(moderate deﬁcit)
CELF-3: 65
(severe deﬁcit)
Poor tongue movements; reduced elevation,
depression and lateral movements,
particularly to the right side.
Reduced lip rounding
Lethargic during assessment.
Hypernasal, mild dysarthria.
6 years 7 months Preschool CELF: 65
(severe deﬁcit)
Preschool CELF: 89
(average range)
Not available Developmental speech sound errors.
Mild dysarthria (slow labored speech).
Breathy voice quality
7 years 3 months CELF-3: 64
(severe deﬁcit)
CELF-3: 75
(moderate deﬁcit)
Not available Highly anxious during assessment.
Mild word ﬁnding difﬁculties.
Dysphonic voice quality. Mild dysarthria.
8 years 10 months CELF-3: 66
(severe deﬁcit)
CELF-3: 92
(average range)
Not available Quiet with little spontaneous speech.
Slow processing of verbal information.
Nasal speech with oral motor difﬁculties.
Speech intelligible
10 years 4 months CELF-4: 76
(moderate deﬁcit)
CELF-4: 80
(mild deﬁcit)
Reduced lip rounding, clumsy tongue
movements, reduced movement to the right
Quiet with little spontaneous speech.
Speech intelligible
13 years 1 month CELF-4: 68 (severe deﬁcit)
TROG: 88 (average range)
BPVS: 66 (severe)
CELF-4: 77
(moderate deﬁcit)
EVT: 73
(moderate deﬁcit)
Reduced lip rounding, reduced tongue tip
elevation and reduced movement of tongue
to the right
Speech intelligible
Good interaction with therapist
Abbreviations: Preschool CELF= Preschool Clinical Evaluation of Language Fundamentals; CELF-3= 3rd Ed.; CELF-4= 4th Ed.; BPVS= British Picture Vocabulary Scale; TROG= Test for
Reception of Grammar; EVT=Expressive Vocabulary Test (2nd Ed.). Scores: Clinical Evaluation of Language Fundamentals, CELF (average range: 86–115), EVT (standard score reported),
TROG (average range: 86–115).
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veloped oromotor difﬁculties, characterized at follow-up assessments
(Table 1). These did not signiﬁcantly impact on speech,whichwas intel-
ligible; however, eating was messy, and oral hygiene was challenging.
He was noted to have difﬁculties with muscles of the lips, cheek, and
tongue. These included a reduced range ofmovement of the lips (unable
to round lips/blow out cheeks, with clumsy tongue movements; unable
to move tongue towards the right, to lick lips to clear food residue).
These movements were subsequently achieved during speech, eating,
and drinking at follow-up, but residual difﬁculties are seen. As the epi-
leptic activity started in the anterior sylvian region (facial weakness,
slurring of speech), it correlated with residual nonlinguistic oromotorTable 2
Early cognitive proﬁle.
Scaled score Percentile rank
WPPSI-R (4.11 years)
Performance score 97 (average) 42
Verbal score 88 (low average) 21
Full scale score 91 (average) 27
WPPSI-III (6.7 years)
Verbal scale 90 (average) 25
Performance scale 82 (low average) 8
Processing speed 64 (impaired) 1
Full Scale score 80 (low average) 5
Abbreviations: WPPSI-R, Wechsler Preschool and Primary Scale of Intelligence— Revised;
WPPSI-III, Wechsler Preschool and Primary Scale of Intelligence— 3rd Edition (UK).
Table 3
Primary (mainstream) school cognitive proﬁle.
WISC-IV Age 7.7 years Age 8.5 y
Verbal comprehension 83 (low average) 87 (low a
Perceptual reasoning 82 (low average) 77 (borde
Working memory 62 (extremely low) 77 (borde
Processing speed 68 (extremely low) 85 (low a
Full scale I.Q. 70 (borderline) 77 (borde
Abbreviation: WISC-IV, Wechsler Intelligence Scale for Children— 4th Edition (UK).problems (feeding, ﬁne oromotor gestures) but not at the speech pro-
gramming level (no features of verbal dyspraxia) (Table 1).
2.1.5. Cognitive development & neuropsychological assessments
In association with exacerbation of seizures, there was deterioration
in language, oromotor, learning (cognitive), and social communication
skills and increased anxiety. Cognitive developmental trajectory was
monitored with serial neuropsychological assessments. Initial assess-
ment at almost 5 years indicated overall functioningwithin the average
range of ability (WPPSI-R; Table 2). Follow-up assessments between
ages 6–12 years indicated a continued downward shift across cognitive
domains (WISC-IV; Table 3) correlating initiallywith the active epilepsy
period. The most recent assessment indicates residual cognitive func-
tioning overall in the extremely low range (I.Q. range: 55–69)withmin-
imal improvement in workingmemory and processing speed (Table 3).
He attended a mainstream primary (junior) school with learning sup-
port and currently attends a mainstream secondary (senior) school in
a class for students with learning disabilities. Therefore, cognitive dete-
rioration occurred between 5 and 7 years of age during the most active
epilepsy period (including CSWS). Thereafter, the global IQ scores
remained relatively stable with little “recovery”.
Assessment of memory skills also revealed impaired functioning
across both visual and verbalmemory tasks with fall-off in verbalmem-
ory capacity as noted at themost recent assessment (Table 4). However,
school attainment testing indicates a reverse trend to that found on cog-
nitive assessment with evidence of continued gain in the acquirement
of basic academic skills over the period of ages 7 to 12 years, progress
correlating with good seizure control (Table 5).ears Age 9.11 years Age 12.10 years
verage) 79 (borderline) 73 (borderline)
rline) 67 (extremely low) 69 (extremely low)
rline) 74 (borderline) 74 (borderline)
verage) 83 (low average) 78 (borderline)
rline) 70 (borderline) 68 (extremely low)
Table 4
Verbal and visual memory skills.
CMS Index score — 7.7 years Index score — 12.10 years
Verbal immediate memory 82 (low average) 78 (borderline)
Verbal delayed memory 88 (low average) 72 (borderline)
Visual immediate memory 63 (impaired) 63 (impaired)
Visual delayed memory 72 (borderline) 72 (borderline)
Abbreviations: CMS, Children's Memory Scale.
Table 5
School attainment skills.
Age 7.7 years 9.11 years 12.10 years
WIAT-II Scaled score Percentile Scaled score Percentile Scaled score Percentile
Word reading 67 1st 71 3rd 79 8th
Reading comprehension – – 66 1st 78 7th
Numerical operations 72 3rd 89 23rd 76 5th
Mathematical reasoning – – 83 13th
Spelling 68 2nd 77 6th 84 14th
Abbreviations: WIAT-II: Wechsler Individual Achievement Test — 2nd Edition (UK).
Table 6
Gene variants identiﬁed by exome sequencing.
Gene Chromosomal position (hg18) cDNA change Protein change MAF
SCN9A chr2:166846542-166846542 A1964G K655R 0.0016
CPA6 chr8:68820873-68820873 C46A P16T 0.00008
SCNM1 chr1:149407366-149407366 C521T A174V 0.0042
Abbreviations: MAF: minor allele frequency.
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While early preschool social communication skills were considered
normal atﬁrst presentation, at initial assessment at 4.11 years, he had ev-
idence of restricted play (speciﬁc interests and repetitive behaviors, such
as his ability to identify various models of cars, well in advance of expec-
tation for his age). He then continued to develop speciﬁc interests, at one
point with the opening and closing times of shops, different sounds from
shop shutters, and speciﬁc animal groups. Hewas observed to have little
spontaneous communication outside the home, although parents re-
ported ﬂuent communication at home. His behavior ﬂuctuated with dif-
ferent phases of seizure exacerbation and treatment. Behavior in school
was good but sometimes challenging at home (e.g., ran wildly, shouting
loudly). Social communication assessment at age 10 years using the
DISCO (Diagnostic Interview for Social and Communication Disorders)
and ADOS (Autism Diagnostic Observation Scale) resulted in a diagnosis
of pervasive developmental disorder not otherwise speciﬁed (PDD-
NOS). The most recent assessment performed on transfer to second
level education (postprimary school, age 13 years) indicated some posi-
tive improvements in social communication. Although he does not initi-
ate communication, he is better able to engagewith people andmaintain
conversation. He continues to have “unusual” interests, engages in repet-
itive behaviors, and requires a signiﬁcant level of learning support.
2.2. Genetics
2.2.1. Exome sequencing methods
Ethics committee approval from Temple St. Children's University
Hospital, Dublin, Ireland and informed parental consent were obtained
to collect clinical data and perform whole exome sequencing on the
proband's extracted DNA. Whole exome sequencing was performed
using the Agilent SureSelectXT All Exon V4 + UTR enrichment kit
(Agilent Technologies, Santa Clara, USA) and sequenced on an
IlluminaHiSeq platform (Illumina Inc., San Diego, California, USA).
Data cleaning and variant calling were performed using standard
methods (see Supplemental Data). As this is a very rare disorder, all var-
iants with a minor allele frequency of N1% were excluded as candidate
disease variants. Variants present in previously reported epilepsy
genes were noted. Primers were designed to validate variants of inter-
est, and inheritance was assessed by Sanger sequencing.
2.2.2. Exome sequence results
Variants with a MAF of b1% were found in 2 genes previously asso-
ciatedwith epilepsy; SCN9A (A1964G) and CPA6 (C46A). A novel variant
was also identiﬁed in SCNM1 (C521T), a known epilepsy-modiﬁer gene(Table 6). All variants were conﬁrmed by Sanger sequencing and inher-
itance tested. The variants in SCN9A and CPA6werematernally inherited
while the variant in SCNM1was paternally inherited (see Supplemental
Data for further results of these variants).3. Discussion
ABPE is considered within the spectrum of the idiopathic focal epi-
lepsies with CSWS now increasingly referred to as the “epilepsy aphasia
spectrum” [2]. This longitudinal study of a patient with ABPE (seizure/
EEG/pharmacotherapy) and detailed correlative neuropsychological
follow-up over several years has not, to our knowledge, been previously
reported, although various degrees of intellectual disability have been
described in this epilepsy “syndrome” (also now known as pseudo-
Lennox syndrome) since Aicardi and Chevrie's [3] initial reports.
In this case, there was clear evidence of an acquired oromotor disor-
der (“epileptic anterior opercular syndrome”) followed by an acquired
complex language disorder, characterized by lexical semantic deﬁcits
in both comprehension and expression but not the typical acquired ver-
bal auditory agnosia of LKS. These problems could be localized initially
to the anterior sylvian region with corresponding epileptiform activity
and, later, to the posterior sylvian area, suggesting that different foci
were active at successive periods of the epileptic process within the
perisylvian region (Supplemental Table 1). A concomitant cognitive de-
terioration was also documented, as well as an apparently acquired au-
tistic spectrum disorder. The cognitive deterioration occurred during
the period of CSWS and then improved slightly over the subsequent
years to a stable below-average IQ. In follow-up studies of children
with CSWS, similar cognitive outcomes have been reported, but the spe-
ciﬁc language problems in this case appear unique [4]. While the cogni-
tive and social communicative deﬁcits may have contributed to the low
language performances, neither can explain the speciﬁc, more severe
language disorder which should be considered a separatemanifestation
of the epileptic disease involving other networks.
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tive deﬁcit (autistic spectrum) is less clear than that of the other deﬁcits
observed in this case. However, early social communicative develop-
ment before the epilepsy started (23 months) and in the subsequent 1
to 2 years preceding the marked worsening of the epilepsy did not
arouse the clinical suspicion of a pervasive developmental disorder, al-
though subtle features may have been present (hyperlexia, repetitive
behavior, speciﬁc interests). It is possible therefore (as seen in some
childrenwith acquired epileptic aphasia who have preexisting develop-
mental language deﬁcit) that a mild pervasive developmental disorder
was already present and unmasked further or exacerbated, as the epi-
lepsy worsened. The borderland between speciﬁc language impairment
(formerly “pragmatic language disorder”) and autistic disorders is not
clearly deﬁned, and features of either disorder can become more obvi-
ous over time or occasionally disappear [5], suggesting shared and over-
lapping networks that may be immature or deﬁcient within this group
of epilepsies. Further similar prospective case studies may clarify
whether there are acquired, potentially drug responsive, and reversible
epileptic “autistic regression” patterns and their context within the
spectrum of language disorders [6].
While very few reports of children with ABPE or focal epilepsy with
CSWS describe speciﬁc types of language impairment correlated with
the active epilepsy, the contribution of inherited or genetic factors (be-
sides the epileptic process per se) to such outcomes is even less well un-
derstood [22]. Recently, the identiﬁcation of GRIN2A variants in a small
subset of familial and sporadic cases of idiopathic focal epilepsy, partic-
ularly thosewith CSWS, has been a signiﬁcant breakthrough [7,8,9]. The
genotypic expression of most idiopathic focal epilepsies may reﬂect
multiple genes and/or the presence of gene modiﬁers contributing to
the various phenotypes, but for the most part, the molecular mecha-
nisms have yet to be elucidated.
The proband was found to harbor variants in several important epi-
lepsy genes. One variant (p.K655R) occurred in SCN9A, a sodium chan-
nel gene causally associated with febrile seizures, afebrile seizures,
and refractory focal epilepsy [10]. SCN9A variants may also play a role
in Dravet syndrome [11], and the same p.K655R variant identiﬁed in
the proband has also been found in an individual with genetically gen-
eralized (formerly idiopathic generalized) epilepsy and febrile seizures
and in two patients with Dravet syndrome, one of whom also harbored
a de novo SCN1A variant [10]. While the role of sodium channelopathy
genes is established in epilepsy, our understanding of the effects of
modiﬁer genes (including sodium channel genes themselves) is still
evolving [10,11,12]. SCNM1 (sodium channel modiﬁer 1) is one of the
few signiﬁcant epilepsy-modiﬁer genes known and has been shown to
modify the splicing of SCN8A, a gene responsible for epileptic encepha-
lopathy in humans [13]. In the proband, the SCNM1 variant may have
contributed to the biological effect of variant in SCN9A and/or CPA6 (car-
boxypeptidase A6), a nonion channel protein that displays awide range
of neuronal functions in the brain [14]. Variants in CPA6 have been iden-
tiﬁed in patients with temporal lobe epilepsy and febrile seizures [14,
15] including the same variant (p.P16T) present in this proband. Other
rare, novel, and previously reported variants in known epilepsy genes
including those associated with “rolandic epilepsy”, CSWS, and ABPE
(i.e., epilepsy aphasia spectrum) were not identiﬁed in the proband
(Supplemental Data) [7,8,9,16–22].
Although already shown to play important pathogenic roles in epi-
lepsy and predicted to signiﬁcantly alter protein function, the p.K655R
and p.P16T variants were both detected in the proband's asymptomatic
mother and have been found in a very small number of control individ-
uals (NHLBI Exome Sequencing Project). Incomplete penetrance,where-
by some individuals carry an allele but do not display a disease trait, has
been previously reported in various epilepsies including idiopathic focal
epilepsies associated with GRIN2A variants [9]. Furthermore, polygenic
heterogeneity for this complex spectrumof epilepsies and the contribut-
ing mechanisms of the underlying genotype are likely to emerge as fur-
ther cases are analyzed using next generation sequencing [22].In conclusion, the idiopathic focal epilepsies with CSWS, including
ABPE, may affect development or lead to regression in any/all of
motor, language, cognitive, and social communication functions.Wede-
tected potentially pathogenic variants in relevant epilepsy genes in a
boywith ABPE, broadening our understanding of the molecular mecha-
nisms contributing to such disorders.While such complex genomic var-
iations may play a role in many neurodevelopmental disorders without
epilepsy or predating epilepsy onset, this detailed longitudinal follow-
up of a child with ABPE, characterized by deterioration, stabilization,
and improvement in certain aspects of motor, cognitive, language, and
social communication dysfunctions, correlated with the onset and
course of the speciﬁc epilepsy syndrome. Thus, it seems that the epilep-
tic discharges per se signiﬁcantly contribute to such manifestations
within this complex group of genetically determined epileptic disor-
ders. Similar prospective longitudinal follow-up studies are important
to understand new or speciﬁc disordered proﬁles (e.g., lexical semantic
deﬁcit in this case), hiddenwithin this spectrumof epilepsies, and to en-
hance our understanding of the underlying developmental neuronal
networks involved in their pathogenesis.
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